Search research articles
Contact Us
Filters
Showing results (51-60 of 74) with videos related to
Page
of 8
Sort By:
Annals of Hematology
|
June 29, 2011
Efficacy of rituximab in immune thrombocytopenic purpura: a retrospective survey
Souleymane Brah, Laurent Chiche, Raphaelle Fanciullino, et al.
Seminars in Arthritis and Rheumatism
|
August 18, 2021
Considering the level of myositis-specific autoantibodies could improve the precision of multiplex assay : lesson from patients with multiple positive results
Antoine Briantais, Benjamin De Sainte Marie, Emmanuelle Campana-Salort, et al.
Gastroenterologie Clinique Et Biologique
|
January 2, 2008
[Pancreatic tuberculosis: an unusual cause of obstructive jaundice accessible to endoscopic management]
Patrick Borentain, Philippe Grandval, Pascal Ananian, et al.
Annals of Biomedical Engineering
|
June 20, 2006
In vitro experiments and numerical simulations of airflow in realistic nasal airway geometry
Céline Croce, Redouane Fodil, Marc Durand, et al.
Autoimmunity Reviews
|
November 9, 2018
Autoimmune diseases in myelodysplastic syndrome favors patients survival: A case control study and literature review
Julie Seguier, Véronique Gelsi-Boyer, Mikael Ebbo, et al.
Head & Neck
|
October 10, 2023
Early detection of pharyngocutaneous fistulae after total laryngectomy by cytokine in drainage: A pilot study (DEFILAC)
Nicolas Saroul, Margaux Loukine, Marc Durand, et al.
Plos One
|
May 3, 2014
Particle deposition in a child respiratory tract model: in vivo regional deposition of fine and ultrafine aerosols in baboons
Iolanda Albuquerque-Silva, Laurent Vecellio, Marc Durand, et al.
Pharmaceutical Research
|
September 26, 2013
Validation of anatomical models to study aerosol deposition in human nasal cavities
Sandrine Le Guellec, Deborah Le Pennec, Stephane Gatier, et al.
American Journal of Hematology
|
June 27, 2013
Efficacy and safety of rituximab given at 1,000 mg on days 1 and 15 compared to the standard regimen to treat adult immune thrombocytopenia
Matthieu Mahévas, Mikael Ebbo, Sylvain Audia, et al.
European Journal of Internal Medicine
|
March 9, 2010
Low prevalence of anti-RNA polymerase III antibodies in a French scleroderma population: anti-RNA polymerase III scleroderma
Benoit Faucher, Philippe Stein, Brigitte Granel, et al.
Page
of 8
Search research articles
Search
Showing results (51-60 of 74) with videos related to
Sort By:
Page
of 8
Annals of Hematology
|
June 29, 2011
Efficacy of rituximab in immune thrombocytopenic purpura: a retrospective survey
Souleymane Brah, Laurent Chiche, Raphaelle Fanciullino, et al.
Seminars in Arthritis and Rheumatism
|
August 18, 2021
Considering the level of myositis-specific autoantibodies could improve the precision of multiplex assay : lesson from patients with multiple positive results
Antoine Briantais, Benjamin De Sainte Marie, Emmanuelle Campana-Salort, et al.
Gastroenterologie Clinique Et Biologique
|
January 2, 2008
[Pancreatic tuberculosis: an unusual cause of obstructive jaundice accessible to endoscopic management]
Patrick Borentain, Philippe Grandval, Pascal Ananian, et al.
Annals of Biomedical Engineering
|
June 20, 2006
In vitro experiments and numerical simulations of airflow in realistic nasal airway geometry
Céline Croce, Redouane Fodil, Marc Durand, et al.
Autoimmunity Reviews
|
November 9, 2018
Autoimmune diseases in myelodysplastic syndrome favors patients survival: A case control study and literature review
Julie Seguier, Véronique Gelsi-Boyer, Mikael Ebbo, et al.
Head & Neck
|
October 10, 2023
Early detection of pharyngocutaneous fistulae after total laryngectomy by cytokine in drainage: A pilot study (DEFILAC)
Nicolas Saroul, Margaux Loukine, Marc Durand, et al.
Plos One
|
May 3, 2014
Particle deposition in a child respiratory tract model: in vivo regional deposition of fine and ultrafine aerosols in baboons
Iolanda Albuquerque-Silva, Laurent Vecellio, Marc Durand, et al.
Pharmaceutical Research
|
September 26, 2013
Validation of anatomical models to study aerosol deposition in human nasal cavities
Sandrine Le Guellec, Deborah Le Pennec, Stephane Gatier, et al.
American Journal of Hematology
|
June 27, 2013
Efficacy and safety of rituximab given at 1,000 mg on days 1 and 15 compared to the standard regimen to treat adult immune thrombocytopenia
Matthieu Mahévas, Mikael Ebbo, Sylvain Audia, et al.
European Journal of Internal Medicine
|
March 9, 2010
Low prevalence of anti-RNA polymerase III antibodies in a French scleroderma population: anti-RNA polymerase III scleroderma
Benoit Faucher, Philippe Stein, Brigitte Granel, et al.
Page
of 8